logo

Quick Facts

Share SHARE

Norwegian energy firm Statoil ASA (STO) Monday said the subscription period for its previously announced Scrip Dividend Programme will commence on May 30 and expire on June 10. On May 10, the company made a resolution at the annual general meeting to approve the two year scrip dividend programme commencing...

tHE European Commission granted marketing authorization in the European Union for FLIXABI, an infliximab biosimilar referencing Remicade. FLIXABI was developed by Samsung Bioepis, the joint venture between Samsung BioLogics and Biogen (BIIB). FLIXABI is indicated for the treatment of adults with rheumatoid...

eLong, Inc. (LONG), a mobile and online travel service provider in China, announced Monday that its shareholders voted in favor of the proposal to authorize and approve its previously announced merger at today's extraordinary general meeting. It was on February 4 that eLong said it has entered into...

Coca-Cola European Partners plc (CCE) announced Saturday that the combination of Coca-Cola Enterprises, Inc., Coca-Cola Iberian Partners S.A.U., and Coca-Cola Erfrischungsgetränke GmbH is now complete. This combination creates the world's largest independent Coca-Cola bottler based on net sales and...

Intercept Pharmaceuticals, Inc. (ICPT), a biopharmaceutical company focused on non-viral, progressive liver diseases, announced late Friday that the U.S. Food and Drug Administration or FDA has granted accelerated approval to Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis...

AbbVie (ABBV), a research-based biopharmaceutical company, and Biogen (BIIB) late Friday announced that the U.S. Food and Drug Administration or FDA approved ZINBRYTA (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis or RMS. Biogen...

O'Reilly Automotive, Inc. (ORLY), a retailer in the automotive aftermarket industry, announced Friday that its Board of Directors approved a resolution to increase the authorization amount under its share repurchase program by an additional $750 million, raising the aggregate authorization under the...

Lincoln Financial Group (LNC) announced that the board of directors of Lincoln National Corporation declared a quarterly cash dividend of $0.25 per share on the corporation's common stock. The dividend on the common stock will be payable August 1, 2016 to shareholders of record at the close of business...

A. M. Castle & Co. (CAS), a global distributor of specialty metal and supply chain solutions, announced that it has reached an agreement with Raging Capital Management, LLC on the composition of the Company's Board of Directors and matters relating to the 2016 annual meeting of shareholders. As per...

Baxalta Inc. (BXLT) announced its shareholders approved the definitive merger agreement with Shire plc (SHPG, SHP.L), dated as of January 11, 2016, and the merger transaction, with approximately 98.9 percent of shares outstanding cast in favor of the proposal. Earlier, Shire shareholders of approximately...

Nexstar Broadcasting Group, Inc. (NXST) said it has entered into three definitive agreements to divest five television stations in four markets. The proposed divestitures mark an important first step in fulfilling Nexstar's commitment to regulatory bodies to consummate its previously announced agreement...

Terex Corp. (TEX) announced discussions with Zoomlion Heavy Industry Science and Technology Co. regarding the purchase of Terex, either with or without the MHPS segment, have been terminated. TEX is closed Thursday's regular trading at $24.33, down $0.87 or 3.45 percent. In the Friday Pre-Market trade,...

Johnson Controls (JCI) and Tyco International (TYC) announced the senior executive team that will lead the combined company following the close of their planned merger, which is expected on or around October 1, 2016. As previously announced, at the effective time of the merger, Johnson Controls chairman...

Merck & Co. Inc. (MRK) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending approval of ZEPATIER (elbasvir and grazoprevir), an investigational, once-daily, fixed-dose combination tablet for the treatment...

Gilead Sciences Inc. (GILD) announced that the Committee for Medicinal Products for Human Use or CHMP, the scientific committee of the European Medicines Agency or EMA, has adopted a positive opinion on the company's Marketing Authorization Application or MAA for Epclusa, an investigational, pan-genotypic,...

Follow RTT